Literature DB >> 18534852

Use of complementary therapies by Australian women with breast cancer.

T Kremser1, A Evans, A Moore, K Luxford, S Begbie, A Bensoussan, R Marigliani, H Zorbas.   

Abstract

International research suggests complementary therapy usage is common in women with breast cancer. Comparable data do not exist for Australia. A self-completed questionnaire was used to survey Australian women with breast cancer about their usage of complementary therapies. The survey was mailed to members of two breast cancer consumer advocacy groups, and assessed type of therapy used, reasons for use, and sources of information about complementary therapies. Of 367 respondents with breast cancer, 87.5% had used complementary therapies, with many using four or more therapies. Most commonly used were vitamin supplements (54.2%), support groups (49.8%), massage (41.4%) and meditation (38.7%). Common reasons for use included improving physical (86.3%) and emotional (83.2%) wellbeing and boosting the immune system (68.8%). Women sought information about complementary therapies from a variety of sources. The range of therapies used and the diverse reasons for use emphasise the need for reliable, evidence-based information about complementary therapies for women and clinicians.

Entities:  

Mesh:

Year:  2008        PMID: 18534852     DOI: 10.1016/j.breast.2007.12.006

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  25 in total

1.  Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?

Authors:  J S McLay; D Stewart; J George; C Rore; S D Heys
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

2.  Depression, mood, stress, and Th1/Th2 immune balance in primary breast cancer patients undergoing classical massage therapy.

Authors:  Michaela Krohn; Miriam Listing; Gracia Tjahjono; Anett Reisshauer; Eva Peters; Burghard F Klapp; Martina Rauchfuss
Journal:  Support Care Cancer       Date:  2010-07-20       Impact factor: 3.603

3.  Complementary and alternative medicine use in patients with hematological cancers in Malaysia.

Authors:  G G Gan; Y C Leong; P C Bee; E Chin; A K H Teh
Journal:  Support Care Cancer       Date:  2015-01-22       Impact factor: 3.603

Review 4.  Phytotherapy and Nutritional Supplements on Breast Cancer.

Authors:  C M Lopes; A Dourado; R Oliveira
Journal:  Biomed Res Int       Date:  2017-08-06       Impact factor: 3.411

Review 5.  Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.

Authors:  Kate E Roberts; India T Adsett; Kirsty Rickett; Sophie M Conroy; Mark D Chatfield; Natasha E Woodward
Journal:  Cochrane Database Syst Rev       Date:  2022-01-10

6.  A longitudinal analysis of phenotypic and symptom characteristics associated with inter-individual variability in employment interference in patients with breast cancer.

Authors:  Raymond Javan Chan; Bruce Cooper; Bogda Koczwara; Alexandre Chan; Chia Jie Tan; Steven M Paul; Laura B Dunn; Yvette P Conley; Kord M Kober; Jon D Levine; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2020-01-18       Impact factor: 3.603

7.  Outcome analysis of breast cancer patients who declined evidence-based treatment.

Authors:  Kurian Joseph; Sebastian Vrouwe; Anmmd Kamruzzaman; Ali Balbaid; David Fenton; Richard Berendt; Edward Yu; Patricia Tai
Journal:  World J Surg Oncol       Date:  2012-06-26       Impact factor: 2.754

8.  Use of Chinese medicine by cancer patients: a review of surveys.

Authors:  Bridget Carmady; Caroline A Smith
Journal:  Chin Med       Date:  2011-06-09       Impact factor: 5.455

9.  Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use.

Authors:  Agnete E Kristoffersen; Arne J Norheim; Vinjar M Fønnebø
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-28       Impact factor: 2.629

10.  Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer.

Authors:  Janette Vardy; Haryana M Dhillon; Stephen J Clarke; Inger Olesen; Felicity Leslie; Anne Warby; Jane Beith; Anne Sullivan; Anne Hamilton; Philip Beale; Anneliese Rittau; Andrew J McLachlan
Journal:  Springerplus       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.